Digital Pathology and Artificial Intelligence:
Next Generation of Pathology for Diagnosis and Research
Industry Leading Accuracy
Clinical Decision Support
Custom Tailored Models
Seamless Integration
Products and Services
Flexlis: an integrated LIS, IMS and AI
-
Flexlis LIS: a user-friendly digital pathology reporting system which can be integrated with IMS and AI.
-
Flexlis IMS: a digital pathology software offers state-of-art image management system for categorizing, annotating and viewing histopathology images
-
NovinoAI DX: an AI platform enables cancer detection, prognosis and prediction based on whole slide images.
Laboratory Services
-
NovinoPath: a pathology laboratory accredited by CLIA provides full diagnostic pathology services including histology, immunohistochemistry, fluorescence in situ hybridization, digital PCR, etc.
-
NovinoPath offers research services including tissue processing, slide digitization, image analysis, etc.
-
To visit NovinoPath click this link
Technology Capabilities
-
NovinoAI: a software company specializing in the healthcare space provides consultation and development of AI-based software, including cancer diagnosis, prognosis and prediction.
-
Flexoptik scanner: NovinoAI in partner with Flexoptik offers low cost high quality scanners.
Clinical and Research Partnerships
-
NovinoAI offers digital pathology IMS and AI models for clinical applications
-
NovinoAI's IMS and AI models enhance the research capability for biomarker development and drug discovery.
-
NovinoAI partners with pathology laboratories, academic institutions, and pharmaceutical and biotechnology companies.
Features of NovinoAI Digital Pathology
Open platform and easy to implement
-
Flexlis is an AI assisted and cloud-based system which is turn-key ready and plug-in;
-
Open platform and compatible with most digital slide scanners;
-
Scalable to fit all-size laboratories.
-
Highly secured and regulatorily complained.
-
AI-assisted quality control of images.
-
Patent pending
Pathologist centered and user friendly
-
Access remotely and securely via website; easy and friendly user experience;
-
Viewing images and the slide labels at high quality and speed;
-
Ability to have multiple viewer windows open to simultaneously compare different images or stains;
-
Performing annotation and capture of the images easily;
-
Enable to track, sort and retrieve images and cases;
-
Ability to share the images among different viewers or pathologists;
-
Automatically arranging slide images in an usual slide tray format with sequential order of the images.
Artificial intelligence readiness
-
Ready to incorporate various AI modules;
-
Diseases and cancer diagnostic AI modules in development;
-
Research and collaboration in biomarker discovery.
Benefits of FlexLIS IMS
-
Low entry cost, and no local storage server and maintenance needed;
-
Fully supported by FlexLIS team, including training;
-
Improving the workflow, reducing the staff’s time;
-
Immediate availability of images for pathologists to review.
-
Low cost but high quality Flexoptik scanners is available through NovinoAI partners
Implementation of digital pathology
-
NovinoAI team will provide consultation and full support to implement digital pathology into the practices
-
Factors to be considered:
-
Workflow assessment.
-
Specimen type and volume
-
Number of slides
-
Number of users and locations
-
Space and laboratory staff
-
Features of NovinoAI Artificial Intelligence
What is Pathology Artificial Intelligence
-
Artificial intelligence (AI) refers to the simulation of human intelligence in computer systems, enabling them to replicate human-like thinking processes and behaviors such as learning and problem-solving.
-
Application of AI algorithms in computational pathology, Pathology AI, became possible due to the widespread and adaptation of digital pathology.
-
Various approaches can be employed in this domain, including fully supervised learning, unsupervised learning, and weakly supervised learning.
-
Computational and AI pathology offers great potential in diagnosis, research and biomarker discovery.
NovinoAI platform
-
The pathology AI platform developed by the NovinoAI team is to be used in images of histology slides.
-
The platform is very versatile and flexible in developing AI algorithms based on histology images.
-
The platform can be used for developing AI algorithms for disease diagnosis and treatment, biomarker discovery and validation, etc.
-
AI algorithms developed by NovinoAI team is an open platform that can be used in any image management system, including Image Management System.
Research and collaboration opportunities
-
NovinoAI provides digital pathology services to researchers and tissue banks including digitizing slides, categorizing images, and supporting collaboration.
-
NovinoAI provides data analysis, artificial intelligence and computation consultation.
-
NovinoAI collaborates with researchers from major academic medical institutions to address clinical question and to identify the solutions
-
NovinoAI supports pharma and biotech collaboration in biomarkers and drug discovery and validation
-
NovinoAI provides support for clinical trials by standardizing pathology services, including interpretation and quality controls.
Cui M and Zhang D. Artificial intelligence and computational pathology. Lab Invest 2021 Apr;101(4):412-422. https://pubmed.ncbi.nlm.nih.gov/33454724/
Zhang D. et al. Implantation of Digital Pathology and Artificial Intelligence in Routine Pathology Practice. Lab Invest . 2024 Jul 23: https://pubmed.ncbi.nlm.nih.gov/39053633/
Zhu M et al. Artificial intelligence in pathologic diagnosis, prognosis and prediction of prostate cancer. Am J Clin Exp Urol. 2024 Aug 25;12(4):200-215
About NovinoAI
-
NovinoAI is a software company focused on the development of AI assisted software in the healthcare space.
-
NovinoAI is a leading company developing pathology image management system (IMS) and AI models for routine clinical use.
-
FlexLIS IMS supports pathology laboratories to streamline the process of review, interpretation and diagnosis.
-
NovinoAI provides digital and AI solutions to support research and pharmaceutical collaboration for biomarker and drug discovery.
About Us
-
Pathologists with decades of clinical practice and track record of academic research.
-
Bioinformaticians and data scientists with years of experience in big data and AI fields
-
Computer software engineers with expertise in software and application development
-
Business entrepreneurs and regulatory attorneys to ensure business growth and compliance